Unlock more of Europe with immersive destination discovery and personalized experiences, all with Ce

Benchmark analyst Bill Sutherland initiates coverage on Prenetics Global (NASDAQ:PRE) with a Buy

Prenetics Global (NASDAQ:PRE) affirms Q2 sales outlook from $46.000 million-$48.000 million to $46.0

Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(1.61) per share which missed the analys

Lake Street analyst Ryan Meyers initiates coverage on Prenetics Global (NASDAQ:PRE) with a Buy ra

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading con

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading hea

Company Continues Portfolio Optimization on the Heels of Successful $72 million ACT Genomics saleCom

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading hea

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading hea

Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading heal

Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), the parent com

Financial OutlookPrenetics reaffirms its full-year 2025 revenue guidance of $90 to $100 million (ful

Financial OutlookPrenetics reaffirms its full-year 2025 revenue guidance of $90 to $100 million (ful

Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.41) per share which beat the analyst

October Revenue Grew 32% MoM and on Track to hit $10 Million in Monthly Revenue by December 2025 ~ P

Additional Bitcoin Acquisition Follows Immediately on $44 Million Equity OfferingCompany now holds a

Cantor Fitzgerald analyst Ross Osborn maintains Prenetics Global (NASDAQ:PRE) with a Overweight a

Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading heal

CHARLOTTE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE), a leading

Prenetics Global Limited (NASDAQ:PRE), a leading consumer health sciences company, announced today a

Prenetics Global Limited (PRE) completes $20 million BTC purchase, aims to become one of the largest

-  Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin

Prenetics Global Limited (NASDAQ:PRE) ("Prenetics"), a leading consumer health sciences comp

Leveraging our strong cash position and robust business fundamentals, management is actively advanci

OutlookThe Company is increasing full-year 2025 revenue guidance to $80 to $100 million from the pre

Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.80) per share which missed the analys

For the first quarter of 2025, we expect consumer results to be:Revenue of $11.5 million to $13 mill

Prenetics Global (NASDAQ:PRE) reported quarterly sales of $10.500 million which missed the analyst c

CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn

Cantor Fitzgerald analyst Ross Osborn reiterates Prenetics Global (NASDAQ:PRE) with a Overweight

Collaboration to Focus on Nutrition, Cellular Rejuvenation, Protein, Collagen and Overall WellnessIM

Cantor Fitzgerald analyst Ross Osborn reiterates Prenetics Global (NASDAQ:PRE) with a Overweight

Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.84) per share which beat the analyst